BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9566421)

  • 1. Cytologically negative carcinomatous meningitis: usefulness of CSF biochemical markers.
    Chamberlain MC
    Neurology; 1998 Apr; 50(4):1173-5. PubMed ID: 9566421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The many forms of carcinomatous meningitis].
    van den Bent MJ; Vecht CJ
    Ned Tijdschr Geneeskd; 1994 Nov; 138(45):2225-9. PubMed ID: 7969605
    [No Abstract]   [Full Text] [Related]  

  • 3. Alkaline phosphatase level in CSF in various brain tumors and pulmonary carcinomatous meningitis.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinchas I
    J Neurooncol; 1990 Aug; 9(1):35-40. PubMed ID: 2213114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcinomatous meningitis presenting with isolated headache].
    Outteryck O; Berteloot D; Senechal O; Fromentin C; Mounier-Vehier F
    Rev Neurol (Paris); 2004 Oct; 160(10):949-51. PubMed ID: 15492724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings.
    Zeller JA; Zunker P; Witt K; Schlueter E; Deuschl G
    Neurol Res; 2002 Oct; 24(7):652-4. PubMed ID: 12392200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinomatous meningitis in solid tumours.
    Jayson GC; Howell A
    Ann Oncol; 1996 Oct; 7(8):773-86. PubMed ID: 8922190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma.
    Groves MD; Hess KR; Puduvalli VK; Colman H; Conrad CA; Gilbert MR; Weinberg J; Cristofanilli M; Yung WK; Liu TJ
    J Neurooncol; 2009 Sep; 94(2):229-34. PubMed ID: 19267183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study of a series of 26 carcinomatous meningitis secondary to lung cancer].
    Hammerer V; Pauli G; Quoix E
    Bull Cancer; 2005 Nov; 92(11):989-94. PubMed ID: 16316833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Tsakonas G; Soukouli G; Gassiamis A; Mylonakis N; Karabelis A
    Med Sci Monit; 2005 Aug; 11(8):CR398-401. PubMed ID: 16049383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Melanomatous meningitis. Apropos of 3 cases].
    Delaunay M; Erny A; Méraud JP; Le Clech C; Verret JL; Géniaux M
    Ann Dermatol Venereol; 1989; 116(9):647-54. PubMed ID: 2688521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
    Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
    Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor in CSF: a biological marker for carcinomatous meningitis.
    Stockhammer G; Poewe W; Burgstaller S; Deisenhammer F; Muigg A; Kiechl S; Schmutzhard E; Maier H; Felber S; Schumacher P; Gunsilius E; Gastl G
    Neurology; 2000 Apr; 54(8):1670-6. PubMed ID: 10762512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].
    Kubo M; Jida M; Yamane M; Miyatani K; Udaka T; Sogabe O; Maeda H; Mizuta M; Shirakawa K
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2097-9. PubMed ID: 16352935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib.
    Dhruva N; Socinski MA
    J Clin Oncol; 2009 Aug; 27(22):e31-2. PubMed ID: 19487379
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carcinomatous meningitis as early manifestation of lung adenocarcinoma].
    Mateos Rodríguez F; Fuertes Martín A; Almeida Parra J; Cuñado A; Jiménez López A
    An Med Interna; 1993 Oct; 10(10):517. PubMed ID: 8136435
    [No Abstract]   [Full Text] [Related]  

  • 16. Carcinomatous meningitis and solid tumours.
    Strady C; Ricciarelli A; Nasca S; Liautaud-Roger F; Coninx P
    Oncol Rep; 2000; 7(1):203-7. PubMed ID: 10601619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma.
    Ferreira Filho AF; Cardoso F; Di Leo A; Awada A; da Silva VD; Tovar RB; Schwartsmann G
    Ann Oncol; 2001 Dec; 12(12):1757-9. PubMed ID: 11843255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cerebrospinal fluid cytology in the diagnosis of cancerous meningitis].
    Xiao L; Xiao B; Liang J; Jiang H; Xie G; Yang X
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):212, 214. PubMed ID: 10681852
    [No Abstract]   [Full Text] [Related]  

  • 19. Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant.
    Jayson GC; Howell A; Harris M; Morgenstern G; Chang J; Ryder WD
    Cancer; 1994 Dec; 74(12):3135-41. PubMed ID: 7982179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib.
    Sakai M; Ishikawa S; Ito H; Ozawa Y; Yamamoto T; Onizuka M; Sakakibara Y
    Int J Clin Oncol; 2006 Jun; 11(3):243-5. PubMed ID: 16850132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.